Lensar (LNSR) Change in Accured Expenses (2019 - 2026)
Lensar's (LNSR) quarterly Change in Accured Expenses came in at -$3.9 million in Q1 2026, down 3853.4% year-on-year from $103000.0 in Q1 2025, and down 170.73% on a QoQ basis from -$1.4 million in Q4 2025.
Lensar (LNSR) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Change in Accured Expenses data on file, last reported at -$3.9 million in Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 3853.4% year-over-year to -$3.9 million in Q1 2026; TTM through Mar 2026 was -$4.3 million, a 253.22% decrease from a year earlier, with the FY2025 full-year figure at -$341000.0, down 127.97% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$3.9 million, down from -$1.4 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for LNSR reached as high as $2.2 million in Q3 2025 and fell as low as -$3.9 million in Q1 2026.
- Historically, Change in Accured Expenses has averaged -$117647.1 across 5 years, with a median of $165000.0 in 2024.
- Across the five-year window, Change in Accured Expenses surged 278.57% in 2024 and sank 3853.4% in 2026, its largest moves.
- Year by year, Change in Accured Expenses stood at -$266000.0 in 2022, then jumped by 200.0% to $266000.0 in 2023, then jumped by 278.57% to $1.0 million in 2024, then tumbled by 241.81% to -$1.4 million in 2025, then slumped by 170.73% to -$3.9 million in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$3.9 million in Q1 2026, -$1.4 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Lensar | 65.43 Mn | 54.33 Mn | 6.38 Mn | -3.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.87 Mn |
| Mar 31, 2026 | -3.87 Mn |
| Dec 31, 2025 | -1.43 Mn |
| Dec 31, 2025 | -1.43 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | -1.18 Mn |
| Jun 30, 2025 | -1.18 Mn |
| Mar 31, 2025 | 103,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Dec 31, 2024 | 1.01 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Mar 31, 2024 | -1.49 Mn |
| Mar 31, 2024 | -1.49 Mn |
| Dec 31, 2023 | 266,000.00 |
| Dec 31, 2023 | 266,000.00 |